| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |